Dr. David Joel Rozansky, MD

Dr. Rozansky practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Rozansky's NPI, 1881600336, was assigned on August 1, 2006. Dr. Rozansky graduated from UC San Diego School of Medicine in 1990. Dr. Rozansky's Oregon license number on file is MD22981.

Dr. Rozansky's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Rozansky's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Rozansky is also affiliated with Asante Rogue Regional Medical Center. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Rozansky to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rozansky practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Rozansky's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Rozansky is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Rozansky's licenses on file in 4 states: Oregon, Washington, California and Illinois.

Dmand AI lists neutropenia among the conditions Dr. Rozansky treats.

CMS counts 11 Medicare patients who saw Dr. Rozansky in 2024. The largest group is under 65, with 11 patients. Their average risk score is 6.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rozansky's median patient age at 12, with 40% women.

In 2024, Dr. Rozansky wrote 41 Medicare Part D claims. 98% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $390 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Rozansky for performance year 2024, reported through an alternative payment model (APM). Dr. Rozansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Rozansky, published from 2006 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Chromogranin A, Chromogranins and Hypertension. Dr. Rozansky has published most often in Pediatr Nephrol. Dr. Rozansky's most frequent co-authors are Sandra Iragorri Iragorri, MD, Randall D. Jenkins, MD and Amira Y. Al-Uzri, MD.

CMS Open Payments shows 3 general payments to Dr. Rozansky from 3 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 71% of the total. Welch Allyn paid the most, $100.

Dr. Rozansky graduated from UC San Diego School of Medicine in 1990.

Dr. Rozansky is in network with 4 carriers, including Aetna, Kaiser Permanente and AK State Medicaid. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.